Published in
Elsevier, The Lancet Oncology, 6(19), p. 768-784
DOI: 10.1016/s1470-2045(18)30204-3
Links
Tools
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial
Journal article published in 2018 by
Giles W. Robinson,
Vasilisa A. Rudneva,
Ivo Buchhalter,
Catherine A. Billups,
Sebastian M. Waszak,
Kyle S. Smith,
Daniel C. Bowers 
,
Anne Bendel,
Paul G. Fisher,
Sonia Partap,
John R. Crawford,
Tim Hassall,
Daniel J. Indelicato,
Frederick Boop,
Paul Klimo
and other authors.
,
Anne Bendel,
Paul G. Fisher,
Sonia Partap,
John R. Crawford,
Tim Hassall,
Daniel J. Indelicato,
Frederick Boop,
Paul Klimo
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 